CPA Applauds President Trump’s Executive Order to Restore U.S. Pharmaceutical Manufacturing
President Trump’s Executive Order is a bold, necessary move to rebuild America’s pharmaceutical industry and protect our citizens.
President Trump’s Executive Order is a bold, necessary move to rebuild America’s pharmaceutical industry and protect our citizens.
Democrats on the Economic Growth, Energy Policy, and Regulatory Affairs Subcommittee—of the House Committee on Oversight and Government Reform—are united against tariffs.
The IPO, widely seen as the first major test of President Trump’s America First Investment Policy (AFIP), directly undermines the President’s February directive to block U.S. investment in companies linked to the Chinese military, human rights abuses, and authoritarian surveillance state.
Foreign imports primarily from Cambodia, Malaysia, Mexico, Thailand, and Vietnam—that are heavily subsidized by China—are destroying American cabinet jobs.
The American people, Congress, and the President have spoken. Now it’s Wall Street’s turn to decide.
Guardian Bikes, an American company out of Seymour, Indiana that sells direct-to-consumer, wants to ensure that it keeps manufacturing 100% of its bicycles right here in the U.S., and to do so, has received a $19 million loan from J.P. Morgan to help them.
The Department’s decision confirms what CPA has consistently warned: Chinese solar companies have been illegally circumventing U.S. trade laws through Southeast Asian shell operations, flooding the U.S. market with dumped and subsidized products directly harming the domestic solar manufacturing industry.
The Department of Defense designated CATL as a “Chinese military company” under Section 1260H of the National Defense Authorization Act on January 7. Their concern: CATL’s advanced lithium-ion batteries may one day be used to power China’s submarine fleet, replacing older battery models.
Tariffs on pharmaceutical companies isn’t just good economic policy — it benefits national security and public health.
Members of the House Ways and Means Committee gave U.S. Trade Representative Jamieson Greer a piece of their mind on Wednesday during a four-and-a-half-hour hearing—double the time he spent with the Senate Finance Committee the day before.